![Kumar Srinivasan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kumar Srinivasan
Direktor/Vorstandsmitglied bei TRANSCENTA HOLDING LIMITED
Vermögen: 6 826 $ am 31.05.2024
Aktive Positionen von Kumar Srinivasan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TRANSCENTA HOLDING LIMITED | Direktor/Vorstandsmitglied | 19.12.2022 | - |
Independent Dir/Board Member | 19.12.2022 | - | |
Pulmotect, Inc.
![]() Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - | - |
Wugen, Inc.
![]() Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Vorstandsvorsitzender | 13.03.2023 | - |
Präsident | 13.03.2023 | - |
Karriereverlauf von Kumar Srinivasan
Ehemalige bekannte Positionen von Kumar Srinivasan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TURG POIN | Corporate Officer/Principal | 01.06.2021 | - |
Ausbildung von Kumar Srinivasan
Case Western Reserve University | Doctorate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
University of Madras | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
China | 2 |
Indien | 2 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TRANSCENTA HOLDING LIMITED | Health Technology |
Private Unternehmen | 3 |
---|---|
Turning Point Therapeutics, Inc.
![]() Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Pulmotect, Inc.
![]() Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Health Technology |
Wugen, Inc.
![]() Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Technology Services |
- Börse
- Insiders
- Kumar Srinivasan
- Erfahrung